Employee compliance rises as medicine copays drop
Incorporating a value-based insurance design (VBID) can increase the use of important medications, according to a new study. The approach complements not only disease management programs but CDHPs as well. The study, led by a team of University of Michigan and Harvard University researchers and published in the January/February Health Affairs, showed that a large private employer significantly increased its employees' use of important chronic-disease medicines by making some free and reducing copays for others. Another employer that kept its copays the same (the control group) didn't experience the same increase.
- Will More Pioneer ACOs Defect?
- Charity HealthCare Conundrum Brewing Among Providers
- MU Final Rule Disappoints Some CIOs
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- Interventional Radiology No Longer a Sub-Specialty
- 'Terrible' Patient Becomes Dedicated Nurse
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- CNO Leads $1M Charge for New Scrubs, Uniforms
- mHealth Tackles Readmissions
- Acute Kidney Injury Gets New Focus